本信息仅供教育用途，不构成医疗建议。请务必咨询合格的医疗专业人员。
说明, 用法用量, 不良反应, 禁忌. Data from EMA, URPL, openFDA and other regulatory sources.
| Ramipril | Lisinopril | |
|---|---|---|
| 活性成分 | RAMIPRIL | LISINOPRIL |
| ATC 代码 | C09AA05 | C09AA03 |
| 剂型 | — | TABLET |
| 用法用量 | — | 40 mg/1 |
| 给药途径 | — | ORAL |
| 生产厂家 | ANGITA PHARMA INC. | PD-Rx Pharmaceuticals, Inc. |
Ramipril (INN: RAMIPRIL, ATC C09AA05) and Lisinopril (INN: LISINOPRIL, ATC C09AA03) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
本信息仅供教育用途，不构成医疗建议。请务必咨询合格的医疗专业人员。